ALFA Filings
Every announcement, straight from the exchange
Every Religare Enterprises management change announcement on NSE and BSE, newest first, each with its own page.
Time
15 announcements
Religare disclosed Mr. Gaurav Sharma as CTO of subsidiary Religare Finvest, effective October 6, 2026. He brings ~30 years of fintech experience from IIFL and L&T Financial.
Religare Enterprises Limited announced a change in designation for Mr. Arjun Lamba. He has transitioned from Wholetime Director to Executive Director.
Religare Enterprises announced the resignation of Anuj Jain, Company Secretary and Compliance Officer, effective from the close of business hours on July 31, 2026.
Religare Enterprises approved the continuation of Mr. Rajender Mohan Malla as Non-Executive Chairperson. His term is extended for the July-September 2026 quarter on a rotational basis.
Religare Enterprises appointed Pavan Kumar Gupta as MD and CEO of its subsidiary RHDFCL. The appointment is effective from July 1, 2026.
Religare Enterprises designated Group General Counsel Babu Rao Priya as Key Managerial Personnel. The move strengthens corporate governance and formalizes senior leadership responsibilities.
Religare Enterprises designated Mr. Babu Rao Priya as Key Managerial Personnel. He continues as Group General Counsel and Group Chief Compliance Officer until November 2030.
Religare Enterprises appointed Mr. Srinivasan Karthik as CEO and Managing Director of its subsidiary Religare Finvest. The leadership change takes effect from May 05, 2026.
Religare Enterprises Limited announced that Mr. Anuj Gulati's tenure as MD & CEO of its subsidiary, Care Health Insurance Limited, ended on April 25, 2026. The company acknowledged his leadership in building the entity into a leading health insurer. No replacement was named in this disclosure.
Religare Enterprises Limited announced the appointment of Mr. Manish Vishnu Dodeja as Whole-time Director of its material subsidiary, Care Health Insurance Limited. The appointment is for a five-year term effective April 26, 2026. IRDAI has already approved the appointment, which remains subject to shareholder approval.
Religare Enterprises Limited announced the appointment of Mr. Ajay Kumar Shah as MD & CEO of its subsidiary, Care Health Insurance Limited (CHIL). The five-year term is effective April 26, 2026, following IRDAI approval. Mr. Shah, currently CHIL's Chief Business Officer, brings over 30 years of experience to the role, subject to shareholder approval.
Religare Enterprises Limited announced the resignation of Richa Mishra, effective April 6, 2026. This update follows a routine management change disclosure under Regulation 30. Investors typically monitor such key personnel exits for impacts on leadership continuity and corporate governance.
Richa Mishra has resigned from her position at Religare Enterprises Limited, effective April 6, 2026. This change in the company's management team was disclosed in a regulatory filing to the NSE.
Religare Enterprises Limited announced the resignation of Richa Mishra, effective April 6, 2026. The change in key managerial personnel was filed with the NSE as a regulatory disclosure under Regulation 30. This is a routine leadership transition and does not carry an immediate financial impact.
Dr. Richa Mishra has resigned as Director & Group Head – Human Resources (Senior Managerial Personnel) of Religare Enterprises Limited, effective April 06, 2026. Her departure is attributed to personal reasons. The company has filed the necessary disclosures under SEBI Regulation 30.